Budesonide for Maintenance Treatment of Collagenous Colitis

Collagenous Colitis Clinical Trial

Official title:
Efficacy and Safety of Budesonide in Maintenance Treatment of Collagenous Colitis

Status Completed

Clinical Trial Summary

The purpose of this study is to determine whether orale budesonide is effective in maintaining clinical remission in patients with collagenous colitis.

Clinical Trial Description

The purpose of this study is to determine whether orale budesonide is effective in maintaining clinical remission in patients with collagenous colitis. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00180076
Study type	Interventional
Source	Technische Universität Dresden
Contact
Status	Completed
Phase	Phase 3
Start date	July 2004
Completion date	March 2008

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT00139165` - Long-Term Treatment of Collagenous Colitis With Budesonide	Phase 3
Not yet recruiting	`NCT03658993` - Rifaximin-treatment of Collagenous Colitis	Phase 3
Completed	`NCT00450086` - Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis	Phase 3
Recruiting	`NCT01504048` - Usefulness of Chromoendoscopy in Diagnosing Microscopic Colitis	N/A
Completed	`NCT01928667` - Case-Control Study to Identify Risk Factors for Microscopic Colitis	N/A